Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

HUTCHMED to Receive First Commercial Milestone Payment From Takeda for Exceeding US$200 Million in FRUZAQLA® Sales

Oct 31, 2024•over 1 year ago

Contract Type

partnership

BiotechnologyHealth CareBiopharma

Description

HUTCHMED announces it will receive a US$20 million milestone payment from Takeda for surpassing US$200 million in sales of FRUZAQLA® for metastatic colorectal cancer. Takeda has the exclusive worldwide license to develop, commercialize, and manufacture fruquintinib outside of mainland China, Hong Kong, and Macau, marketing it under the brand FRUZAQLA®.

Company Information

Company

HUTCHMED (China) Limited

About

HUTCHMED is a biopharmaceutical company based in China, listed on Nasdaq/AIM:​HCM and HKEX:​13. It focuses on developing and commercializing innovative oncology and immunology medicines

Predictive Intelligence
Strategic

ML-powered predictions for HUTCHMED (China) Limited's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.